Learn More
PURPOSE The objective of this study was to determine whether the addition of trastuzumab to chemotherapy in the neoadjuvant setting could increase pathologic complete response (pCR) rate in patients(More)
PURPOSE Findings from our previously published phase III randomized trial showed a high pathologic complete remission (CR) rate in patients with human epidermal growth factor receptor 2-positive(More)
A case of adult nephroblastoma in a 51-year-old woman is reported. A percutaneous aspiration biopsy did not lead to the right diagnosis presumably because the histologic structure of the tumour(More)